Data may be delayed — last successful sync 2026-09-26 (18 days ago). Figures reflect the most recent completed ingest.
Company profile
Quest Diagnostics Incorporated
NYSE: DGX · Healthcare · Medical - Diagnostics & Research
#40 of 1,417 Healthcare companies by revenue58th-percentile growth
EA Score
88AFH 88DQ 99GM 63SS 95
v0.1 · 65/100 weight · provisional
↑ filing timeliness, disclosure history · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$11.3B
Rev growth YoY (TTM)
+11.0%
Net income (FY)
$992.0M
Employees
51,500
as of 2026-09-05
Market cap
$26.2B
as of 2026-09-05
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$11.0B$11.0B2025
Net income$992.0M$992.0M2025
Operating income$1.6B$1.6B2025
Total assets$16.2B$16.2B2025
Equity$7.2B$7.2B2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Diagnostic Information Services Business100%
By geography
Not disclosed.
The read
What is Quest Diagnostics Incorporated’s revenue?
Quest Diagnostics Incorporated booked $11.0B in FY2025 revenue, growing 12% year over year — about the middle of the pack among Healthcare companies we track, at a 9.0% net margin.
Peers · Healthcare
Community Health Systems, Inc.74BVertex Pharmaceuticals Incorporated88ABaxter International Inc.78B+Bausch Health Companies Inc.82B+Intuitive Surgical, Inc.90ABiogen Inc.85ANeighbors
Hudson →Key facts
CEOJames E. Davis
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersSecaucus, NJ
ExchangeNYSE: DGX
Employees51,500
IPO date1996-12-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.